

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | transcytosis (GO:0045056) | 8.18012261 |
| 2 | intestinal absorption (GO:0050892) | 8.13800234 |
| 3 | cholesterol catabolic process (GO:0006707) | 7.38613296 |
| 4 | sterol catabolic process (GO:0016127) | 7.38613296 |
| 5 | cobalamin metabolic process (GO:0009235) | 7.24586555 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 6.91286169 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 6.91286169 |
| 8 | peptidyl-proline hydroxylation (GO:0019511) | 6.52819091 |
| 9 | negative regulation of digestive system process (GO:0060457) | 6.37083611 |
| 10 | cysteine metabolic process (GO:0006534) | 6.24392393 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.99880590 |
| 12 | glycolipid catabolic process (GO:0019377) | 5.89755016 |
| 13 | membrane lipid catabolic process (GO:0046466) | 5.80993992 |
| 14 | regulation of phospholipase A2 activity (GO:0032429) | 5.75154697 |
| 15 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.37162030 |
| 16 | proline biosynthetic process (GO:0006561) | 5.33590412 |
| 17 | protein maturation by protein folding (GO:0022417) | 5.28672159 |
| 18 | response to peptidoglycan (GO:0032494) | 5.25609123 |
| 19 | ceramide catabolic process (GO:0046514) | 5.18933226 |
| 20 | positive regulation of nuclease activity (GO:0032075) | 5.14318135 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.13853972 |
| 22 | valine metabolic process (GO:0006573) | 5.01932923 |
| 23 | protein hydroxylation (GO:0018126) | 5.00996301 |
| 24 | branched-chain amino acid catabolic process (GO:0009083) | 4.91176308 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 4.90931728 |
| 26 | endocrine pancreas development (GO:0031018) | 4.90277012 |
| 27 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.80053697 |
| 28 | response to endoplasmic reticulum stress (GO:0034976) | 4.70233386 |
| 29 | regulation of nuclease activity (GO:0032069) | 4.67381234 |
| 30 | cellular response to unfolded protein (GO:0034620) | 4.65966913 |
| 31 | cellular modified amino acid catabolic process (GO:0042219) | 4.65781156 |
| 32 | intestinal epithelial cell development (GO:0060576) | 4.47164141 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 4.45420337 |
| 34 | ER-nucleus signaling pathway (GO:0006984) | 4.45292040 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 4.44603918 |
| 36 | cellular response to topologically incorrect protein (GO:0035967) | 4.43993561 |
| 37 | COPII vesicle coating (GO:0048208) | 4.42950072 |
| 38 | zinc ion transport (GO:0006829) | 4.42211763 |
| 39 | signal peptide processing (GO:0006465) | 4.39515480 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.37867769 |
| 41 | 4-hydroxyproline metabolic process (GO:0019471) | 4.32304368 |
| 42 | serine family amino acid biosynthetic process (GO:0009070) | 4.19502730 |
| 43 | detection of other organism (GO:0098543) | 4.18812779 |
| 44 | detection of bacterium (GO:0016045) | 4.17481552 |
| 45 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.09173547 |
| 46 | maintenance of protein localization in organelle (GO:0072595) | 4.08707247 |
| 47 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.07882732 |
| 48 | aspartate family amino acid catabolic process (GO:0009068) | 4.06183928 |
| 49 | negative regulation of growth of symbiont in host (GO:0044130) | 4.04625148 |
| 50 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.04625148 |
| 51 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.04625148 |
| 52 | regulation of growth of symbiont in host (GO:0044126) | 4.04625148 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.04210568 |
| 54 | mitochondrial calcium ion transport (GO:0006851) | 3.95741483 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.93074122 |
| 56 | L-phenylalanine catabolic process (GO:0006559) | 3.93074122 |
| 57 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.92398505 |
| 58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.91129971 |
| 59 | modulation by symbiont of host immune response (GO:0052553) | 3.91129971 |
| 60 | positive regulation by symbiont of host defense response (GO:0052509) | 3.91129971 |
| 61 | modulation by symbiont of host defense response (GO:0052031) | 3.91129971 |
| 62 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.91129971 |
| 63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.91129971 |
| 64 | cell wall macromolecule catabolic process (GO:0016998) | 3.83792494 |
| 65 | response to unfolded protein (GO:0006986) | 3.81954656 |
| 66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.81236285 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 3.77989822 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.77519904 |
| 69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.77234279 |
| 70 | glutamine metabolic process (GO:0006541) | 3.77188351 |
| 71 | steroid catabolic process (GO:0006706) | 3.76456765 |
| 72 | microglial cell activation (GO:0001774) | 3.73542567 |
| 73 | GDP-mannose metabolic process (GO:0019673) | 3.73463192 |
| 74 | ER overload response (GO:0006983) | 3.73371705 |
| 75 | leukotriene biosynthetic process (GO:0019370) | 3.71707182 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.71366102 |
| 77 | L-phenylalanine metabolic process (GO:0006558) | 3.71366102 |
| 78 | autophagic vacuole fusion (GO:0000046) | 3.69394429 |
| 79 | response to topologically incorrect protein (GO:0035966) | 3.68813235 |
| 80 | neutrophil activation (GO:0042119) | 3.68154131 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 3.67933741 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 3.67410418 |
| 83 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.67410418 |
| 84 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.65221818 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 3.63870541 |
| 86 | proline metabolic process (GO:0006560) | 3.63347668 |
| 87 | peptidyl-asparagine modification (GO:0018196) | 3.62778518 |
| 88 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.62019978 |
| 89 | cellular extravasation (GO:0045123) | 3.58766225 |
| 90 | coenzyme catabolic process (GO:0009109) | 3.57511858 |
| 91 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.57120491 |
| 92 | regulation of mast cell activation (GO:0033003) | 3.56725078 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.54795557 |
| 94 | positive regulation of B cell differentiation (GO:0045579) | 3.54731999 |
| 95 | granulocyte activation (GO:0036230) | 3.52849882 |
| 96 | creatine metabolic process (GO:0006600) | 3.50665022 |
| 97 | positive regulation of heat generation (GO:0031652) | 3.47314535 |
| 98 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45283955 |
| 99 | B cell mediated immunity (GO:0019724) | 3.42459855 |
| 100 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.39339525 |
| 101 | leukocyte degranulation (GO:0043299) | 3.38351070 |
| 102 | serine family amino acid metabolic process (GO:0009069) | 3.36012143 |
| 103 | sphingolipid catabolic process (GO:0030149) | 3.35822140 |
| 104 | regulation of hypersensitivity (GO:0002883) | 3.35029507 |
| 105 | L-serine metabolic process (GO:0006563) | 3.34174461 |
| 106 | protein N-linked glycosylation (GO:0006487) | 3.33636760 |
| 107 | regulation of chemokine biosynthetic process (GO:0045073) | 3.33569609 |
| 108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33148321 |
| 109 | phagosome maturation (GO:0090382) | 3.30154396 |
| 110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.26647533 |
| 111 | regulation of fever generation (GO:0031620) | 3.26425811 |
| 112 | cell redox homeostasis (GO:0045454) | 3.23278894 |
| 113 | sterol transport (GO:0015918) | 3.20680515 |
| 114 | cholesterol transport (GO:0030301) | 3.20680515 |
| 115 | pancreas development (GO:0031016) | 3.19379825 |
| 116 | antibacterial humoral response (GO:0019731) | 3.17499333 |
| 117 | neutrophil mediated immunity (GO:0002446) | 3.16669194 |
| 118 | response to muramyl dipeptide (GO:0032495) | 3.14294297 |
| 119 | cell wall macromolecule metabolic process (GO:0044036) | 3.12814218 |
| 120 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.11768703 |
| 121 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.11459004 |
| 122 | organelle membrane fusion (GO:0090174) | 3.10948570 |
| 123 | macrophage activation (GO:0042116) | 3.10585747 |
| 124 | regulation of antigen processing and presentation (GO:0002577) | 3.10548825 |
| 125 | sulfur amino acid catabolic process (GO:0000098) | 3.10322495 |
| 126 | mast cell activation (GO:0045576) | 3.10296278 |
| 127 | digestive system process (GO:0022600) | 3.08607605 |
| 128 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.08367308 |
| 129 | myeloid leukocyte mediated immunity (GO:0002444) | 3.03587525 |
| 130 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.03561137 |
| 131 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.02552880 |
| 132 | regulation of germinal center formation (GO:0002634) | 3.02454516 |
| 133 | regulation of leukocyte degranulation (GO:0043300) | 3.00248895 |
| 134 | vesicle coating (GO:0006901) | 2.99319697 |
| 135 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98776106 |
| 136 | response to host immune response (GO:0052572) | 2.98776106 |
| 137 | Golgi organization (GO:0007030) | 2.98084515 |
| 138 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98049248 |
| 139 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.96157009 |
| 140 | nucleotide salvage (GO:0043173) | 2.96049625 |
| 141 | antimicrobial humoral response (GO:0019730) | 2.94996930 |
| 142 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.94008160 |
| 143 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93365096 |
| 144 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93357226 |
| 145 | detection of external biotic stimulus (GO:0098581) | 2.92973492 |
| 146 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.91586874 |
| 147 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.87615130 |
| 148 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.87423070 |
| 149 | lysine metabolic process (GO:0006553) | 2.87297226 |
| 150 | lysine catabolic process (GO:0006554) | 2.87297226 |
| 151 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86340997 |
| 152 | glandular epithelial cell differentiation (GO:0002067) | 2.85051446 |
| 153 | sulfur amino acid biosynthetic process (GO:0000097) | 2.83964306 |
| 154 | production of molecular mediator of immune response (GO:0002440) | 2.83652667 |
| 155 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83634803 |
| 156 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.82573446 |
| 157 | respiratory burst (GO:0045730) | 2.82084409 |
| 158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81926688 |
| 159 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80752853 |
| 160 | positive regulation of B cell mediated immunity (GO:0002714) | 2.80243738 |
| 161 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.80243738 |
| 162 | positive regulation of humoral immune response (GO:0002922) | 2.79392712 |
| 163 | phagocytosis, engulfment (GO:0006911) | 2.78506327 |
| 164 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.76741942 |
| 165 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76298260 |
| 166 | purine nucleotide salvage (GO:0032261) | 2.74677379 |
| 167 | regulation of regulated secretory pathway (GO:1903305) | 2.74422401 |
| 168 | N-acetylneuraminate metabolic process (GO:0006054) | 2.73491383 |
| 169 | glycine metabolic process (GO:0006544) | 2.72757277 |
| 170 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.71891472 |
| 171 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.71677956 |
| 172 | biotin metabolic process (GO:0006768) | 2.71328045 |
| 173 | negative regulation of phagocytosis (GO:0050765) | 2.71273487 |
| 174 | alpha-amino acid biosynthetic process (GO:1901607) | 2.71162598 |
| 175 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.70677068 |
| 176 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.70631202 |
| 177 | negative regulation of cell killing (GO:0031342) | 2.70631202 |
| 178 | germinal center formation (GO:0002467) | 2.70449230 |
| 179 | peptide catabolic process (GO:0043171) | 2.70283365 |
| 180 | regulation of B cell differentiation (GO:0045577) | 2.69754149 |
| 181 | cellular protein catabolic process (GO:0044257) | 2.69661281 |
| 182 | positive regulation of type 2 immune response (GO:0002830) | 2.69245375 |
| 183 | tetrapyrrole metabolic process (GO:0033013) | 2.69171354 |
| 184 | regulation of interleukin-12 production (GO:0032655) | 2.67860222 |
| 185 | polarized epithelial cell differentiation (GO:0030859) | 2.67365568 |
| 186 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.67123746 |
| 187 | positive regulation of regulated secretory pathway (GO:1903307) | 2.65829419 |
| 188 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.65676333 |
| 189 | positive regulation of interleukin-17 production (GO:0032740) | 2.65347067 |
| 190 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.64213812 |
| 191 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64163076 |
| 192 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.63645743 |
| 193 | icosanoid secretion (GO:0032309) | 2.63203803 |
| 194 | detection of molecule of bacterial origin (GO:0032490) | 2.62437533 |
| 195 | intestinal cholesterol absorption (GO:0030299) | 17.5575278 |
| 196 | digestion (GO:0007586) | 13.0785019 |
| 197 | protein retention in ER lumen (GO:0006621) | 11.9015373 |
| 198 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 11.3085670 |
| 199 | * exocrine pancreas development (GO:0031017) | 10.5519123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.76972185 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.36661631 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.01525992 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.06421741 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.89138802 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.43648160 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.39915995 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.37598695 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34354018 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.25753271 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.21511568 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.18764916 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06961270 |
| 14 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.06218366 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01324318 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.99945388 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.96577852 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.90999678 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.90784289 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.89328872 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.83050336 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.78811268 |
| 23 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77130848 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76279432 |
| 25 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.59842636 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.56850216 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.56187090 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52859950 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.48952633 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.47327221 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.47171912 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46537914 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23364253 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20519721 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20369832 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.15023089 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 2.14131736 |
| 38 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11804297 |
| 39 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.10231488 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.10117089 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.05505822 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.01436123 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.00920146 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00171364 |
| 45 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97872669 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.96066097 |
| 47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.94027195 |
| 48 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90201327 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88240861 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.86249971 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84931336 |
| 52 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81654931 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76469999 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74660262 |
| 55 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.73597454 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72759879 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70596938 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67762378 |
| 59 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.67093880 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60534251 |
| 61 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.60450155 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56808238 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55962348 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54972244 |
| 65 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54730743 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51390425 |
| 67 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.50763093 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48339152 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47114206 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46475338 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45896523 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45601675 |
| 73 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45304231 |
| 74 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45256600 |
| 75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40946299 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40706476 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.40562224 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.40200427 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40060905 |
| 80 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39816878 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38310690 |
| 82 | MYB_26560356_Chip-Seq_TH1_Human | 1.37882799 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37117249 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35925819 |
| 85 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.35590333 |
| 86 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35567541 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34994451 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34805613 |
| 89 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33674893 |
| 90 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33083534 |
| 91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.32865559 |
| 92 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.32865559 |
| 93 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.32865559 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29999815 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28866526 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28681113 |
| 97 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28059209 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27600903 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25688972 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25502331 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24677569 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23458749 |
| 103 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.22870448 |
| 104 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.22676420 |
| 105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19906192 |
| 106 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18851393 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.17201016 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16818327 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16806542 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15887356 |
| 111 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15264376 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15125891 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14548281 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13694975 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10991521 |
| 116 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.10799913 |
| 117 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09927465 |
| 118 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09680377 |
| 119 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08367738 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.08337669 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07719200 |
| 122 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07488723 |
| 123 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07444459 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06917951 |
| 125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05989404 |
| 126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05525137 |
| 127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05466129 |
| 128 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04316965 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02702505 |
| 130 | * P68_20966046_ChIP-Seq_HELA_Human | 1.02151406 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00438054 |
| 132 | MAF_26560356_Chip-Seq_TH2_Human | 1.00390121 |
| 133 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00236715 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00090845 |
| 135 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98613165 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97857552 |
| 137 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96796004 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96307334 |
| 139 | P300_27268052_Chip-Seq_Bcells_Human | 0.96137746 |
| 140 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95956319 |
| 141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95178819 |
| 142 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.94942988 |
| 143 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94664638 |
| 144 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94480967 |
| 145 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94311531 |
| 146 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94065460 |
| 147 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.90465211 |
| 148 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89907175 |
| 149 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89900997 |
| 150 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89686988 |
| 151 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88962962 |
| 152 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88768229 |
| 153 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88716807 |
| 154 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87768214 |
| 155 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87691464 |
| 156 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.87442164 |
| 157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86935348 |
| 158 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86597541 |
| 159 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86496090 |
| 160 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86206018 |
| 161 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85939506 |
| 162 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.85469558 |
| 163 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85142711 |
| 164 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84753748 |
| 165 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84355590 |
| 166 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.84111834 |
| 167 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.83106681 |
| 168 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82837364 |
| 169 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82832468 |
| 170 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82812088 |
| 171 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82812088 |
| 172 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82385611 |
| 173 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82371419 |
| 174 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81986655 |
| 175 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81266738 |
| 176 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.80627711 |
| 177 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79999826 |
| 178 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77179113 |
| 179 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.76466390 |
| 180 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76057241 |
| 181 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75733026 |
| 182 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.75199020 |
| 183 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75005879 |
| 184 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.74332521 |
| 185 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.73930925 |
| 186 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.70994910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 8.51641417 |
| 2 | MP0001666_abnormal_nutrient_absorption | 8.49975943 |
| 3 | MP0005220_abnormal_exocrine_pancreas | 6.45149936 |
| 4 | MP0005365_abnormal_bile_salt | 6.32719868 |
| 5 | MP0003868_abnormal_feces_composition | 4.86913018 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 4.81548037 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.76178040 |
| 8 | MP0002254_reproductive_system_inflammat | 3.45891566 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.37019760 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.32664368 |
| 11 | MP0003303_peritoneal_inflammation | 3.32419067 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 3.18002255 |
| 13 | MP0002693_abnormal_pancreas_physiology | 3.07292414 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 3.04948659 |
| 15 | MP0006082_CNS_inflammation | 3.01206665 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.94569852 |
| 17 | MP0003724_increased_susceptibility_to | 2.85527292 |
| 18 | MP0003436_decreased_susceptibility_to | 2.83456647 |
| 19 | MP0005671_abnormal_response_to | 2.79779134 |
| 20 | MP0002419_abnormal_innate_immunity | 2.76723188 |
| 21 | MP0008260_abnormal_autophagy | 2.68632968 |
| 22 | MP0000685_abnormal_immune_system | 2.61875186 |
| 23 | MP0009785_altered_susceptibility_to | 2.54024039 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.51211490 |
| 25 | MP0003959_abnormal_lean_body | 2.50128938 |
| 26 | MP0005025_abnormal_response_to | 2.44928601 |
| 27 | MP0001800_abnormal_humoral_immune | 2.37521365 |
| 28 | MP0001664_abnormal_digestion | 2.31726713 |
| 29 | MP0009278_abnormal_bone_marrow | 2.31659994 |
| 30 | MP0001944_abnormal_pancreas_morphology | 2.30070749 |
| 31 | MP0002452_abnormal_antigen_presenting | 2.27899983 |
| 32 | MP0002723_abnormal_immune_serum | 2.20480814 |
| 33 | MP0003252_abnormal_bile_duct | 2.17212249 |
| 34 | MP0002420_abnormal_adaptive_immunity | 2.16339243 |
| 35 | MP0005387_immune_system_phenotype | 2.14204247 |
| 36 | MP0001790_abnormal_immune_system | 2.14204247 |
| 37 | MP0001819_abnormal_immune_cell | 2.12677650 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.94143151 |
| 39 | MP0002928_abnormal_bile_duct | 1.89529949 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.86169939 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.81579379 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.78055694 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.78055694 |
| 44 | MP0009764_decreased_sensitivity_to | 1.76632823 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.75218745 |
| 46 | MP0009840_abnormal_foam_cell | 1.72172304 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.69742213 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.68587987 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.60807849 |
| 50 | MP0002398_abnormal_bone_marrow | 1.60565919 |
| 51 | MP0000716_abnormal_immune_system | 1.59742456 |
| 52 | MP0005448_abnormal_energy_balance | 1.54882852 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.47884174 |
| 54 | MP0002405_respiratory_system_inflammati | 1.47185042 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.47068048 |
| 56 | MP0000343_altered_response_to | 1.44106445 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.42165460 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.41819246 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.38961042 |
| 60 | MP0003638_abnormal_response/metabolism_ | 1.36517433 |
| 61 | MP0008469_abnormal_protein_level | 1.33854190 |
| 62 | MP0002429_abnormal_blood_cell | 1.32855770 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.31834880 |
| 64 | MP0003283_abnormal_digestive_organ | 1.29561736 |
| 65 | MP0005332_abnormal_amino_acid | 1.29463762 |
| 66 | MP0005310_abnormal_salivary_gland | 1.29388834 |
| 67 | MP0002722_abnormal_immune_system | 1.29115962 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 1.28660357 |
| 69 | MP0004947_skin_inflammation | 1.27788533 |
| 70 | MP0003787_abnormal_imprinting | 1.23470287 |
| 71 | MP0004233_abnormal_muscle_weight | 1.23450158 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.20781352 |
| 73 | MP0008004_abnormal_stomach_pH | 1.20481554 |
| 74 | MP0000604_amyloidosis | 1.19506267 |
| 75 | MP0006054_spinal_hemorrhage | 1.16338988 |
| 76 | MP0005165_increased_susceptibility_to | 1.15988339 |
| 77 | MP0001853_heart_inflammation | 1.11607813 |
| 78 | MP0003718_maternal_effect | 1.11402967 |
| 79 | MP0000858_altered_metastatic_potential | 1.11130127 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.10818937 |
| 81 | MP0003075_altered_response_to | 1.10336111 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 1.10334376 |
| 83 | MP0008872_abnormal_physiological_respon | 1.08934167 |
| 84 | MP0009643_abnormal_urine_homeostasis | 1.06783391 |
| 85 | MP0001851_eye_inflammation | 1.06605282 |
| 86 | MP0000003_abnormal_adipose_tissue | 1.06604935 |
| 87 | MP0003045_fibrosis | 1.05512127 |
| 88 | MP0005451_abnormal_body_composition | 1.00698797 |
| 89 | MP0009780_abnormal_chondrocyte_physiolo | 1.00258717 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 1.00064940 |
| 91 | MP0000470_abnormal_stomach_morphology | 0.99144233 |
| 92 | MP0003828_pulmonary_edema | 0.97279827 |
| 93 | MP0005410_abnormal_fertilization | 0.96991051 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.95054499 |
| 95 | MP0008057_abnormal_DNA_replication | 0.94852732 |
| 96 | MP0005647_abnormal_sex_gland | 0.93222936 |
| 97 | MP0004043_abnormal_pH_regulation | 0.92067481 |
| 98 | MP0005408_hypopigmentation | 0.91893671 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.91809782 |
| 100 | MP0000703_abnormal_thymus_morphology | 0.87997356 |
| 101 | MP0005360_urolithiasis | 0.87698740 |
| 102 | MP0003953_abnormal_hormone_level | 0.86785849 |
| 103 | MP0002132_abnormal_respiratory_system | 0.85513470 |
| 104 | MP0005535_abnormal_body_temperature | 0.84846062 |
| 105 | MP0004510_myositis | 0.83983589 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.83777039 |
| 107 | MP0003866_abnormal_defecation | 0.81294941 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.81077737 |
| 109 | MP0001873_stomach_inflammation | 0.80606250 |
| 110 | MP0003195_calcinosis | 0.80154606 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.79404396 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.78129107 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.77771006 |
| 114 | MP0009763_increased_sensitivity_to | 0.77076250 |
| 115 | MP0000613_abnormal_salivary_gland | 0.75542896 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.75348094 |
| 117 | MP0010329_abnormal_lipoprotein_level | 0.73880963 |
| 118 | MP0005166_decreased_susceptibility_to | 0.73855139 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.73441605 |
| 120 | MP0001905_abnormal_dopamine_level | 0.69933167 |
| 121 | MP0000490_abnormal_crypts_of | 0.69367178 |
| 122 | MP0004381_abnormal_hair_follicle | 0.66899190 |
| 123 | MP0005377_hearing/vestibular/ear_phenot | 0.66809343 |
| 124 | MP0003878_abnormal_ear_physiology | 0.66809343 |
| 125 | MP0000609_abnormal_liver_physiology | 0.65857341 |
| 126 | MP0003690_abnormal_glial_cell | 0.64696625 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.64660331 |
| 128 | MP0004883_abnormal_blood_vessel | 0.64429970 |
| 129 | MP0003448_altered_tumor_morphology | 0.64118955 |
| 130 | MP0000598_abnormal_liver_morphology | 0.63969350 |
| 131 | MP0005164_abnormal_response_to | 0.62559992 |
| 132 | MP0000372_irregular_coat_pigmentation | 0.62116639 |
| 133 | MP0001663_abnormal_digestive_system | 0.59983958 |
| 134 | MP0005452_abnormal_adipose_tissue | 0.59878728 |
| 135 | MP0003186_abnormal_redox_activity | 0.58477167 |
| 136 | MP0005390_skeleton_phenotype | 0.57813586 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.54970772 |
| 138 | MP0002909_abnormal_adrenal_gland | 0.54934733 |
| 139 | MP0002876_abnormal_thyroid_physiology | 0.54758710 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.54685041 |
| 141 | MP0008438_abnormal_cutaneous_collagen | 0.54509283 |
| 142 | MP0001764_abnormal_homeostasis | 0.54165450 |
| 143 | MP0000013_abnormal_adipose_tissue | 0.54041269 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.52568498 |
| 145 | MP0002896_abnormal_bone_mineralization | 0.50830645 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.50440811 |
| 147 | MP0001731_abnormal_postnatal_growth | 0.50417180 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.49588137 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.48035957 |
| 150 | MP0005187_abnormal_penis_morphology | 0.46531893 |
| 151 | MP0005636_abnormal_mineral_homeostasis | 0.45784098 |
| 152 | MP0003943_abnormal_hepatobiliary_system | 0.45254442 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.45130197 |
| 154 | MP0001765_abnormal_ion_homeostasis | 0.44179714 |
| 155 | MP0008875_abnormal_xenobiotic_pharmacok | 0.41728852 |
| 156 | MP0009642_abnormal_blood_homeostasis | 0.41394746 |
| 157 | MP0002098_abnormal_vibrissa_morphology | 0.41028456 |
| 158 | MP0003656_abnormal_erythrocyte_physiolo | 0.41023577 |
| 159 | MP0005334_abnormal_fat_pad | 0.40452742 |
| 160 | MP0003172_abnormal_lysosome_physiology | 0.40192632 |
| 161 | MP0010386_abnormal_urinary_bladder | 0.39363668 |
| 162 | MP0003795_abnormal_bone_structure | 0.36403554 |
| 163 | MP0008789_abnormal_olfactory_epithelium | 0.36313077 |
| 164 | MP0001756_abnormal_urination | 0.35597186 |
| 165 | MP0004185_abnormal_adipocyte_glucose | 0.34983490 |
| 166 | MP0002089_abnormal_postnatal_growth/wei | 0.34409472 |
| 167 | MP0003329_amyloid_beta_deposits | 0.34347336 |
| 168 | MP0009703_decreased_birth_body | 0.32323340 |
| 169 | MP0002234_abnormal_pharynx_morphology | 0.32037632 |
| 170 | MP0002796_impaired_skin_barrier | 0.31674293 |
| 171 | MP0000371_diluted_coat_color | 0.29848492 |
| 172 | MP0000462_abnormal_digestive_system | 0.29578196 |
| 173 | MP0000367_abnormal_coat/_hair | 0.29106255 |
| 174 | MP0002069_abnormal_eating/drinking_beha | 0.29007530 |
| 175 | MP0001348_abnormal_lacrimal_gland | 0.28975003 |
| 176 | MP0002060_abnormal_skin_morphology | 0.28182045 |
| 177 | MP0000377_abnormal_hair_follicle | 0.27911712 |
| 178 | MP0004272_abnormal_basement_membrane | 0.27288221 |
| 179 | MP0009672_abnormal_birth_weight | 0.26933594 |
| 180 | MP0002168_other_aberrant_phenotype | 0.25517529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 7.52270796 |
| 2 | Gout (HP:0001997) | 6.60571480 |
| 3 | Fat malabsorption (HP:0002630) | 6.58254227 |
| 4 | Decreased subcutaneous fat (HP:0001002) | 5.22455099 |
| 5 | Exocrine pancreatic insufficiency (HP:0001738) | 4.98500415 |
| 6 | Short chin (HP:0000331) | 4.98445598 |
| 7 | Abnormal pancreas size (HP:0012094) | 4.82948033 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 4.74649417 |
| 9 | Abnormality of subcutaneous fat tissue (HP:0001001) | 4.68103058 |
| 10 | Type I diabetes mellitus (HP:0100651) | 4.64122459 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.49868126 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.49868126 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.49868126 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.44613320 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.32825344 |
| 16 | Myositis (HP:0100614) | 4.30731016 |
| 17 | Ketoacidosis (HP:0001993) | 4.30395923 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.23967424 |
| 19 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.14632275 |
| 20 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.14632275 |
| 21 | Stomatitis (HP:0010280) | 4.13224355 |
| 22 | Maternal diabetes (HP:0009800) | 4.04471916 |
| 23 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.02908026 |
| 24 | Increased circulating renin level (HP:0000848) | 3.99559210 |
| 25 | Hypoglycemic seizures (HP:0002173) | 3.99267694 |
| 26 | Ketosis (HP:0001946) | 3.98693000 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.93242045 |
| 28 | Optic neuritis (HP:0100653) | 3.93242045 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.84982915 |
| 30 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.77525748 |
| 31 | Orchitis (HP:0100796) | 3.75494269 |
| 32 | Late onset (HP:0003584) | 3.70836384 |
| 33 | Recurrent abscess formation (HP:0002722) | 3.67426857 |
| 34 | Recurrent bacterial skin infections (HP:0005406) | 3.66318320 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.64509149 |
| 36 | Hypoplasia of the pons (HP:0012110) | 3.56103240 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.55974885 |
| 38 | Keratoconjunctivitis (HP:0001096) | 3.54793297 |
| 39 | Tubulointerstitial fibrosis (HP:0005576) | 3.48178386 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 3.47806602 |
| 41 | Pancreatitis (HP:0001733) | 3.45916873 |
| 42 | Thrombocytosis (HP:0001894) | 3.42171829 |
| 43 | Obstructive lung disease (HP:0006536) | 3.39615964 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39615964 |
| 45 | Abnormality of the pons (HP:0007361) | 3.34976422 |
| 46 | Prolonged bleeding time (HP:0003010) | 3.33139340 |
| 47 | Tetany (HP:0001281) | 3.31990602 |
| 48 | Eczematoid dermatitis (HP:0000976) | 3.29292170 |
| 49 | Joint stiffness (HP:0001387) | 3.27202298 |
| 50 | Mutism (HP:0002300) | 3.26762227 |
| 51 | Abnormality of the common coagulation pathway (HP:0010990) | 3.17466797 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 3.11861815 |
| 53 | Premature skin wrinkling (HP:0100678) | 3.10753897 |
| 54 | Petechiae (HP:0000967) | 3.06830834 |
| 55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.06387817 |
| 56 | Increased purine levels (HP:0004368) | 3.02998704 |
| 57 | Hyperuricemia (HP:0002149) | 3.02998704 |
| 58 | Recurrent fungal infections (HP:0002841) | 3.00502086 |
| 59 | Symptomatic seizures (HP:0011145) | 2.99681101 |
| 60 | Loss of speech (HP:0002371) | 2.98901880 |
| 61 | Meningitis (HP:0001287) | 2.98551211 |
| 62 | Epistaxis (HP:0000421) | 2.97705870 |
| 63 | Eosinophilia (HP:0001880) | 2.95557254 |
| 64 | Paralysis (HP:0003470) | 2.88411271 |
| 65 | Granulocytopenia (HP:0001913) | 2.86391902 |
| 66 | Hypomagnesemia (HP:0002917) | 2.84726919 |
| 67 | Purpura (HP:0000979) | 2.81729993 |
| 68 | Hyperglycemia (HP:0003074) | 2.81728263 |
| 69 | Hypokalemic alkalosis (HP:0001949) | 2.81643442 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.80880522 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76546287 |
| 72 | Tubulointerstitial nephritis (HP:0001970) | 2.75375188 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.75252213 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.73292602 |
| 75 | Hypoproteinemia (HP:0003075) | 2.72771579 |
| 76 | Vasculitis (HP:0002633) | 2.70659718 |
| 77 | Cortical dysplasia (HP:0002539) | 2.70228549 |
| 78 | Amyloidosis (HP:0011034) | 2.69659929 |
| 79 | Encephalitis (HP:0002383) | 2.68779793 |
| 80 | Abnormality of magnesium homeostasis (HP:0004921) | 2.68533261 |
| 81 | Pustule (HP:0200039) | 2.67576691 |
| 82 | Leukocytosis (HP:0001974) | 2.66739224 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.66544168 |
| 84 | Hyperglycinemia (HP:0002154) | 2.64720219 |
| 85 | Recurrent skin infections (HP:0001581) | 2.62286153 |
| 86 | Hemoptysis (HP:0002105) | 2.60630141 |
| 87 | Esophageal varix (HP:0002040) | 2.59657514 |
| 88 | Spontaneous hematomas (HP:0007420) | 2.58835830 |
| 89 | Abnormal drinking behavior (HP:0030082) | 2.57678898 |
| 90 | Polydipsia (HP:0001959) | 2.57678898 |
| 91 | Large for gestational age (HP:0001520) | 2.57253361 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.56192324 |
| 93 | Unilateral renal agenesis (HP:0000122) | 2.55856384 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55486014 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55486014 |
| 96 | Abnormality of purine metabolism (HP:0004352) | 2.47489559 |
| 97 | Abnormality of eosinophils (HP:0001879) | 2.46844481 |
| 98 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45269555 |
| 99 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44474330 |
| 100 | Abnormal protein glycosylation (HP:0012346) | 2.43331231 |
| 101 | Abnormal glycosylation (HP:0012345) | 2.43331231 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.43331231 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.43331231 |
| 104 | Disinhibition (HP:0000734) | 2.41679462 |
| 105 | Congenital glaucoma (HP:0001087) | 2.40852104 |
| 106 | Facial shape deformation (HP:0011334) | 2.40368176 |
| 107 | Potter facies (HP:0002009) | 2.40368176 |
| 108 | Abnormal tarsal ossification (HP:0008369) | 2.40116484 |
| 109 | Autoimmune hemolytic anemia (HP:0001890) | 2.39799357 |
| 110 | Gangrene (HP:0100758) | 2.39375954 |
| 111 | Intrahepatic cholestasis (HP:0001406) | 2.35636000 |
| 112 | Increased IgM level (HP:0003496) | 2.35633232 |
| 113 | Carpal bone hypoplasia (HP:0001498) | 2.35614857 |
| 114 | Abnormality of B cell number (HP:0010975) | 2.35611878 |
| 115 | Prenatal maternal abnormality (HP:0002686) | 2.34626756 |
| 116 | Pulmonary embolism (HP:0002204) | 2.30501328 |
| 117 | Hyperglycinuria (HP:0003108) | 2.30298581 |
| 118 | Progressive muscle weakness (HP:0003323) | 2.29237461 |
| 119 | Abnormality of the renal cortex (HP:0011035) | 2.26104040 |
| 120 | Skin rash (HP:0000988) | 2.25727284 |
| 121 | Increased serum ferritin (HP:0003281) | 2.25318241 |
| 122 | Abnormality of dental color (HP:0011073) | 2.25151735 |
| 123 | Abnormality of glycine metabolism (HP:0010895) | 2.21345002 |
| 124 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21345002 |
| 125 | Polyneuropathy (HP:0001271) | 2.21274025 |
| 126 | Long foot (HP:0001833) | 2.20718925 |
| 127 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.20143185 |
| 128 | Abnormality of the prostate (HP:0008775) | 2.18962468 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17839047 |
| 130 | Urticaria (HP:0001025) | 2.17777060 |
| 131 | Fatigue (HP:0012378) | 2.16651390 |
| 132 | Hypoplasia of the uterus (HP:0000013) | 2.16319641 |
| 133 | Acute hepatic failure (HP:0006554) | 2.16301537 |
| 134 | Optic nerve hypoplasia (HP:0000609) | 2.14736699 |
| 135 | Pectus carinatum (HP:0000768) | 2.14338713 |
| 136 | Chest pain (HP:0100749) | 2.11994856 |
| 137 | Mucopolysacchariduria (HP:0008155) | 2.11976118 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11976118 |
| 139 | Hypergammaglobulinemia (HP:0010702) | 2.10588933 |
| 140 | Ventricular fibrillation (HP:0001663) | 2.10527618 |
| 141 | Neonatal death (HP:0003811) | 2.09492912 |
| 142 | Conjunctival telangiectasia (HP:0000524) | 2.08837159 |
| 143 | Vacuolated lymphocytes (HP:0001922) | 2.08719193 |
| 144 | Anorexia (HP:0002039) | 2.05668299 |
| 145 | Insulin resistance (HP:0000855) | 2.05586532 |
| 146 | Hypoplasia of the odontoid process (HP:0003311) | 2.05089965 |
| 147 | Abnormality of the pleura (HP:0002103) | 2.04860101 |
| 148 | Joint swelling (HP:0001386) | 2.04231818 |
| 149 | Type II lissencephaly (HP:0007260) | 2.03463235 |
| 150 | Abnormality of iron homeostasis (HP:0011031) | 2.02416852 |
| 151 | Hepatosplenomegaly (HP:0001433) | 2.01098050 |
| 152 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00734151 |
| 153 | Generalized aminoaciduria (HP:0002909) | 1.99876493 |
| 154 | Cortical visual impairment (HP:0100704) | 1.99526919 |
| 155 | Tubulointerstitial abnormality (HP:0001969) | 1.99242758 |
| 156 | Gingival bleeding (HP:0000225) | 1.98966593 |
| 157 | Progressive neurologic deterioration (HP:0002344) | 1.96282523 |
| 158 | Arterial thrombosis (HP:0004420) | 1.95878431 |
| 159 | Systemic lupus erythematosus (HP:0002725) | 1.95393391 |
| 160 | Abnormality of methionine metabolism (HP:0010901) | 1.94578413 |
| 161 | Increased IgE level (HP:0003212) | 1.94282336 |
| 162 | Amelogenesis imperfecta (HP:0000705) | 1.94247284 |
| 163 | Glomerulopathy (HP:0100820) | 1.94062359 |
| 164 | Right ventricular cardiomyopathy (HP:0011663) | 1.93690866 |
| 165 | Hypsarrhythmia (HP:0002521) | 1.92210611 |
| 166 | Basal ganglia calcification (HP:0002135) | 1.91889704 |
| 167 | Limb hypertonia (HP:0002509) | 1.91579424 |
| 168 | Severe short stature (HP:0003510) | 1.91380434 |
| 169 | Vertigo (HP:0002321) | 1.90222420 |
| 170 | Abnormality of renin-angiotensin system (HP:0000847) | 1.89090569 |
| 171 | Myocardial infarction (HP:0001658) | 1.88508413 |
| 172 | Acute lymphatic leukemia (HP:0006721) | 1.86823512 |
| 173 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.86595820 |
| 174 | Gastrointestinal infarctions (HP:0005244) | 1.86161009 |
| 175 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85354722 |
| 176 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.85198156 |
| 177 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84302900 |
| 178 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84302900 |
| 179 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84302900 |
| 180 | Sepsis (HP:0100806) | 1.84201062 |
| 181 | Abnormality of T cell number (HP:0011839) | 1.82186444 |
| 182 | EEG with generalized epileptiform discharges (HP:0011198) | 1.81942952 |
| 183 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.81355024 |
| 184 | Ankyloglossia (HP:0010296) | 1.81250399 |
| 185 | Agammaglobulinemia (HP:0004432) | 1.79641050 |
| 186 | Renal salt wasting (HP:0000127) | 1.77712571 |
| 187 | Glucose intolerance (HP:0000833) | 1.77595470 |
| 188 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.77386921 |
| 189 | Abdominal distention (HP:0003270) | 1.77061521 |
| 190 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76833443 |
| 191 | Abnormal foot bone ossification (HP:0010675) | 1.75321252 |
| 192 | Prolonged QT interval (HP:0001657) | 1.73015842 |
| 193 | Methylmalonic aciduria (HP:0012120) | 1.72738698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.49620435 |
| 2 | ERN1 | 5.51678638 |
| 3 | OXSR1 | 4.64579894 |
| 4 | MAP4K1 | 3.97033627 |
| 5 | INSRR | 3.94221191 |
| 6 | EIF2AK3 | 3.90245829 |
| 7 | MAP2K2 | 3.48913118 |
| 8 | RIPK4 | 3.20958195 |
| 9 | TRIB3 | 3.08557762 |
| 10 | TAOK3 | 2.77051539 |
| 11 | PKN2 | 2.69609837 |
| 12 | CSF1R | 2.63136191 |
| 13 | KIT | 2.55831910 |
| 14 | MAPK15 | 2.50261675 |
| 15 | FRK | 2.48341636 |
| 16 | FES | 2.43295393 |
| 17 | TNIK | 2.20841384 |
| 18 | TESK2 | 2.13550547 |
| 19 | BLK | 2.11602839 |
| 20 | SCYL2 | 2.08500915 |
| 21 | TNK2 | 2.06995453 |
| 22 | BMPR2 | 1.92555092 |
| 23 | TXK | 1.88939040 |
| 24 | SYK | 1.84972112 |
| 25 | MATK | 1.82721431 |
| 26 | MAP2K3 | 1.77279365 |
| 27 | ZAP70 | 1.76005644 |
| 28 | MAPKAPK3 | 1.75983657 |
| 29 | IRAK3 | 1.64350709 |
| 30 | WNK4 | 1.63057752 |
| 31 | ACVR1B | 1.56063806 |
| 32 | BTK | 1.56015129 |
| 33 | FLT3 | 1.55416550 |
| 34 | PTK6 | 1.48838466 |
| 35 | CSK | 1.44137486 |
| 36 | MAP3K2 | 1.42608950 |
| 37 | CDK19 | 1.40763569 |
| 38 | TEC | 1.40418207 |
| 39 | LYN | 1.39878183 |
| 40 | ADRBK2 | 1.39620434 |
| 41 | MAP2K1 | 1.38698849 |
| 42 | NME1 | 1.37193959 |
| 43 | JAK3 | 1.35511410 |
| 44 | PAK2 | 1.24313667 |
| 45 | PASK | 1.22719478 |
| 46 | NME2 | 1.22665508 |
| 47 | TYK2 | 1.16980443 |
| 48 | FGR | 1.16126174 |
| 49 | GRK7 | 1.14122180 |
| 50 | SIK1 | 1.12578699 |
| 51 | MAP3K14 | 1.11473679 |
| 52 | IKBKB | 1.11173079 |
| 53 | LCK | 1.10109454 |
| 54 | MAP3K11 | 1.09815433 |
| 55 | PIK3CG | 1.09059780 |
| 56 | ITK | 1.08744096 |
| 57 | HCK | 1.06593694 |
| 58 | PDGFRB | 1.02906809 |
| 59 | MAP3K1 | 0.99663174 |
| 60 | MARK3 | 0.98892692 |
| 61 | DYRK1B | 0.97692395 |
| 62 | CAMKK2 | 0.97311674 |
| 63 | RPS6KB2 | 0.96832384 |
| 64 | FGFR4 | 0.96436505 |
| 65 | HIPK2 | 0.94600304 |
| 66 | RIPK1 | 0.90310077 |
| 67 | ABL2 | 0.90176399 |
| 68 | EPHB1 | 0.87338083 |
| 69 | PRKD3 | 0.87237222 |
| 70 | TGFBR2 | 0.87024251 |
| 71 | PRKCH | 0.84562519 |
| 72 | DYRK1A | 0.82232670 |
| 73 | CAMKK1 | 0.80949915 |
| 74 | GRK6 | 0.79501012 |
| 75 | ARAF | 0.77628689 |
| 76 | LATS1 | 0.75318698 |
| 77 | PDGFRA | 0.75267535 |
| 78 | EEF2K | 0.74934700 |
| 79 | RET | 0.72377138 |
| 80 | PTK2B | 0.71868004 |
| 81 | EPHA3 | 0.71392597 |
| 82 | NTRK1 | 0.70808776 |
| 83 | MTOR | 0.69507631 |
| 84 | PIM2 | 0.68128062 |
| 85 | IKBKE | 0.67743575 |
| 86 | PIK3CA | 0.67361101 |
| 87 | SIK3 | 0.65737471 |
| 88 | PTK2 | 0.64214202 |
| 89 | MET | 0.63834637 |
| 90 | PRKCI | 0.60530028 |
| 91 | FER | 0.60123395 |
| 92 | IRAK2 | 0.59476270 |
| 93 | CDK6 | 0.58291615 |
| 94 | DAPK2 | 0.56685946 |
| 95 | STK39 | 0.54516131 |
| 96 | TAOK2 | 0.53353915 |
| 97 | MAP2K6 | 0.53248763 |
| 98 | JAK2 | 0.53053353 |
| 99 | KSR2 | 0.52408483 |
| 100 | MAP3K5 | 0.50319489 |
| 101 | LRRK2 | 0.47475201 |
| 102 | PRKCD | 0.47342643 |
| 103 | PDPK1 | 0.46762545 |
| 104 | RPS6KA6 | 0.45897517 |
| 105 | MOS | 0.44786116 |
| 106 | MAP3K13 | 0.44076696 |
| 107 | PBK | 0.43719133 |
| 108 | IRAK1 | 0.43531505 |
| 109 | RPS6KL1 | 0.41165504 |
| 110 | RPS6KC1 | 0.41165504 |
| 111 | PIM1 | 0.39372852 |
| 112 | PRKCZ | 0.39227553 |
| 113 | PRKD1 | 0.38586533 |
| 114 | RPS6KB1 | 0.38427910 |
| 115 | TAOK1 | 0.38123828 |
| 116 | BMX | 0.38116044 |
| 117 | IRAK4 | 0.34151519 |
| 118 | PRKD2 | 0.34014356 |
| 119 | MAP3K6 | 0.33803635 |
| 120 | FYN | 0.32676674 |
| 121 | MAP3K3 | 0.31828714 |
| 122 | PRKG2 | 0.31814823 |
| 123 | CAMK1D | 0.31774415 |
| 124 | PDK1 | 0.31672512 |
| 125 | PRKCQ | 0.29197375 |
| 126 | MST1R | 0.29155590 |
| 127 | MAPK3 | 0.29047918 |
| 128 | PKN1 | 0.28539315 |
| 129 | GSK3A | 0.27860626 |
| 130 | TGFBR1 | 0.26955616 |
| 131 | FGFR3 | 0.26248401 |
| 132 | STK10 | 0.24952328 |
| 133 | IGF1R | 0.24934428 |
| 134 | PDK2 | 0.24577977 |
| 135 | MAP4K2 | 0.23868588 |
| 136 | PINK1 | 0.23271011 |
| 137 | TBK1 | 0.23139600 |
| 138 | MAP3K7 | 0.23122951 |
| 139 | NEK6 | 0.22593419 |
| 140 | UHMK1 | 0.22533716 |
| 141 | TLK1 | 0.21653848 |
| 142 | PRKACB | 0.21091310 |
| 143 | GRK1 | 0.20830508 |
| 144 | TESK1 | 0.20276803 |
| 145 | TSSK6 | 0.19449374 |
| 146 | RPS6KA1 | 0.18605590 |
| 147 | PRKAA1 | 0.18121069 |
| 148 | MAPK1 | 0.18120234 |
| 149 | ABL1 | 0.18087911 |
| 150 | MAPK12 | 0.17710772 |
| 151 | JAK1 | 0.17592075 |
| 152 | CDC42BPA | 0.17279853 |
| 153 | CSNK1A1L | 0.16797776 |
| 154 | CSNK1G2 | 0.16610198 |
| 155 | DAPK1 | 0.16342955 |
| 156 | MAPKAPK5 | 0.14858203 |
| 157 | KDR | 0.13383784 |
| 158 | EGFR | 0.12492446 |
| 159 | ILK | 0.12288198 |
| 160 | CSNK1A1 | 0.11787058 |
| 161 | ERBB2 | 0.11455388 |
| 162 | LMTK2 | 0.11271012 |
| 163 | PRKACG | 0.11265675 |
| 164 | MAP3K8 | 0.11013438 |
| 165 | MAPK11 | 0.10757412 |
| 166 | FGFR2 | 0.10273469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 7.92345351 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.69926486 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.34075285 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.77684825 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.58022644 |
| 6 | Asthma_Homo sapiens_hsa05310 | 3.50576152 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.92911214 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.90868898 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.90602347 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.84241177 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.78239192 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.75286016 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71958435 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.68113651 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.64655167 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.64129715 |
| 17 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.50384557 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47409140 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31714116 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 2.25235134 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.19652947 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.18269331 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16070841 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15232445 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.13720219 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03255385 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99158502 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.87418835 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.82128765 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.75460977 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71917933 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64312445 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.60471542 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56070866 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.42389913 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42092151 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41455801 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.38990064 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.38275096 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32619220 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30996737 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.30294656 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29636652 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.22203107 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19591696 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15582639 |
| 47 | Ribosome_Homo sapiens_hsa03010 | 1.15372964 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.10651929 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09919939 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09630482 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.09142332 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08935134 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07290457 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04379880 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03353254 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01832550 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01778485 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.01548957 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01131635 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.99265642 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97735902 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96923709 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95889809 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92991794 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.89312538 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86090045 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84564729 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84057294 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.83282407 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82539804 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80641288 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80255534 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79525948 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79176369 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78976632 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.78484080 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77866380 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76307378 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75031866 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74322729 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.74128195 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73603343 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73537554 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73055103 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72549867 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71950749 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71436931 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70545941 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69780785 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69749196 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68781032 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67533628 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65469934 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65292205 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65143662 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63248464 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62705041 |
| 98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61463495 |
| 99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60146617 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57815588 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.54691204 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54529005 |
| 103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50409879 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49384460 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49041256 |
| 106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49009314 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48806631 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46115815 |
| 109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45115575 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44712508 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.42439662 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41465486 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41013748 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40745561 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40538903 |
| 116 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40190929 |
| 117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40028209 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39708975 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37985586 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.35768826 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35095344 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35020373 |
| 123 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32802918 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31725667 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30645487 |
| 126 | Hepatitis B_Homo sapiens_hsa05161 | 0.30539393 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30151724 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30147776 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29726528 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28953071 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28702692 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28658783 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | 0.28382564 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27552708 |
| 135 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26873794 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26564354 |
| 137 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26274893 |
| 138 | Bile secretion_Homo sapiens_hsa04976 | 0.26062105 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.25622120 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | 0.24771878 |
| 141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.24690277 |
| 142 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.23799196 |
| 143 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23449649 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.23172880 |
| 145 | Peroxisome_Homo sapiens_hsa04146 | 0.22825853 |
| 146 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22684910 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | 0.22555257 |
| 148 | Phototransduction_Homo sapiens_hsa04744 | 0.22546491 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21255105 |
| 150 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.21222120 |
| 151 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21190647 |
| 152 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20976644 |
| 153 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.19763170 |
| 154 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19627252 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.19360676 |
| 156 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18662977 |
| 157 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16947348 |
| 158 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16097053 |
| 159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16082462 |
| 160 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14061838 |
| 161 | Endometrial cancer_Homo sapiens_hsa05213 | 0.12842348 |
| 162 | Alzheimers disease_Homo sapiens_hsa05010 | 0.11902625 |
| 163 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11602181 |
| 164 | Bladder cancer_Homo sapiens_hsa05219 | 0.11402769 |
| 165 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.11009528 |
| 166 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.10732689 |
| 167 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09510135 |
| 168 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09134419 |
| 169 | Prostate cancer_Homo sapiens_hsa05215 | 0.08726027 |
| 170 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.07925805 |
| 171 | Prion diseases_Homo sapiens_hsa05020 | 0.07789541 |
| 172 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06470889 |
| 173 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02862858 |
| 174 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02711021 |
| 175 | Lysine degradation_Homo sapiens_hsa00310 | 0.02412970 |
| 176 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.02363555 |
| 177 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.01900547 |

